Confluent Medical Technologies India Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
- Paid Up Capital ₹ 1.10 M
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 2272.32%
- Profit Growth -184.19%
- Ebitda -181.59%
- Net Worth -365.60%
- Total Assets 162.88%
About Confluent Medical Technologies India
Confluent Medical Technologies India Private Limited (CMTIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 03 September 2021 (Three years and five months 24 days old ). Its registered office is in K.V.Rangareddy, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 1.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prashanth Chintapalli and Matthew Eckl serve as directors at the Company.
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U33129TG2021FTC154608
- Company No.
154608
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
03 Sep 2021
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Healthcare
Manufacturing
Who are the key members and board of directors at Confluent Medical Technologies India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashanth Chintapalli  | Director | 03-Sep-2021 | Current |
Matthew Eckl  | Director | 28-Mar-2023 | Current |
Financial Performance of Confluent Medical Technologies India.
Confluent Medical Technologies India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 2272.32% increase. The company also saw a substantial fall in profitability, with a 184.19% decrease in profit. The company's net worth observed a substantial decline by a decrease of 365.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Confluent Medical Technologies India?
In 2023, Confluent Medical Technologies India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sma Devices Private LimitedPrashanth Chintapalli is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Confluent Medical Technologies India?
Confluent Medical Technologies India has a workforce of 14 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Confluent Medical Technologies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Confluent Medical Technologies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
